T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC

Cellular Immunology

Volumn 217, Issue 1-2, 2002, Pages 78-86

  Haasch, Deanna ^a   Chen, Yung Wu ^a   Reilly, Regina M ^a   Grace Chiou, X ^a   Koterski, Sandra ^a   Smith, Morey L ^a   Kroeger, Paul ^a   McWeeny, Kerri ^a   Halbert, Donald N ^a   Mollison, Karl W ^a   Djuric, Stevan W ^a   Trevillyan, James M ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

Activation; Immunosuppressant drug; Noncoding RNA; Proto oncogene; T cell

Indexed keywords

CD28 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CYCLOSPORIN A; DEXAMETHASONE; IMMUNOSUPPRESSIVE AGENT; MESSENGER RNA; MONOCLONAL ANTIBODY; RAPAMYCIN; TACROLIMUS;

ARTICLE; CELL ASSAY; CELL FUNCTION; CONTROLLED STUDY; DATA BASE; EXPRESSED SEQUENCE TAG; GENETIC CODE; HUMAN; HUMAN CELL; HYBRIDIZATION; NORMAL HUMAN; NORTHERN BLOTTING; ONCOGENE; POLYADENYLATION; PRIORITY JOURNAL; PROTO ONCOGENE; RNA ANALYSIS; RNA TRANSCRIPTION; T LYMPHOCYTE ACTIVATION; TIME;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD28; ANTIGENS, CD3; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CYCLOSPORINE; DEXAMETHASONE; EXPRESSED SEQUENCE TAGS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KINETICS; LYMPHOCYTE ACTIVATION; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENES; RNA, MESSENGER; RNA, UNTRANSLATED; TACROLIMUS; TISSUE DISTRIBUTION; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 18744416255     PISSN: 00088749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-8749(02)00506-3     Document Type: Article

References (36)

1. + T cells in the pathogenesis of organ-specific autoimmune diseases, Immunol. Today 16 (1995) 34.
2. C.A. Chambers, J.P. Allison, Co-stimulation in T cell responses, Curr. Opin. Immumol. 9 (1997) 396.
3. D.J. Lenschow, T.L. Walunas, J.A. Bluestone, CD28/B7 system of T cell costimulation, Annu. Rev. Immunol. 14 (1996) 233.
4. C.H. June, J.A. Bluestone, L.M. Nadler, C.B. Thompson, The B7 and CD28 receptor families, Immunol. Today 15 (1994) 321.
5. R.H. Schwartz, T cell clonal anergy, Curr. Opin. Immunol. 9 (1997) 351.
6. A.C. Chan, D.M. Desai, A. Weiss, The role of protein tyrosine kinases and protein tyrosine phosphatases in T cell antigen receptor signal transduction, Annu. Rev. Immunol. 12 (1994) 555.
7. J.D. Fraser, B.A. Irving, G.R. Crabtree, A. Weiss, Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28, Science 251 (1991) 313.
8. W.G. Butscher, C. Powers, M. Olive, C. Vinson, K. Gardner, Coordinate transactivation of the interleukin-2 response element by c-Rel and ATF-1/CREB2, J. Biol. Chem. 273 (1998) 552.
9. E.V. Rothenberg, S.B. Ward, A dynamic assembly of diverse transcription factors integrates activation and cell-type information for interleukin-2 gene regulation, Proc. Natl. Acad. Sci. USA 93 (1996) 9358.
10. Y. Lu, A. Granelli-Piperno, J.M. Bjorndahl, C.A. Phillips, J.M. Trevillyan, CD28-induced T cell activation: Evidence for a protein-tyrosine kinase signal transduction pathway, J. Immunol. 149 (1992) 24.
11. E.W. Hahaj, S.B. Maggirwar, L. Good, S.-C. Sun, CD28 mediates a potent costimulatory signal for the rapid degradation of IκBβ which is associated with accelerated activation of various NF-κB/Rel heterodimers, Mol. Cell Biol. 16 (1996) 6736.
12. A. Rao, C. Luo, P.G. Hogan, Transcription factors of the NFAT family: Regulation and function, Annu. Rev. Immunol. 15 (1997) 707.
13. J. Liu, J.D. Farmer, W.S. Lane, J. Friedman, I. Weissman, S.L. Schreiber, Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes, Cell 66 (1991) 807.
14. R.M. Nissen, K.R. Yamamoto, The glucocorticoid receptor inhibits NFκB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain, Genes Dev. 14 (2000) 2314.
15. R.E. Morris, In transplantation of the liver; new immunosuppressive drugs, in: R.W. Busuttil, G.B. Klintmalm (Eds.), Title of Book, Saunders, Philadelphia, PA, 1995, p. 760.
16. G.R. Crabtree, Contingent genetic regulatory events in T lymphocyte activation, Science 243 (1989) 355.
17. M.D. Adams, M. Dubnick, A.R. Kerlavage, R. Moreno, J.M. Kelley, T.R. Utterback, J.W. Nagle, C. Fields, Sequence identification of 2375 human brain genes, Nature 355 (1992) 632.
18. W. Tam, Identification and characterization of human BIC, a gene on chromosome 21 that encodes a noncoding RNA, Gene 274 (2001) 157.
19. S.F. Altschul, T.L. Madden, A.A. Schaffer, J. Zhang, Z. Zhang, W. Miller, D.J. Lipman, Gapped BLAST and PSI-BLAST: A new generation of protein database search programs, Nucleic Acids Res. 25 (1997) 3389-3402.
20. W.R. Pearson, T. Wood, Z. Zhang, W. Miller, Comparison of DNA sequences with protein sequences, Genomics 46 (1997) 24-36.
21. J. Sambrook, E.F. Fritsch, T. Maniatis (Eds.) Extraction, purification, and analysis of messenger RNA from eukaryotic cells, in: Molecular Cloning: A Laboratory Manual, vol. 1, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, p. 7.43.
22. C. Dubey, M. Croft, S.L. Swain, Naïve and effector CD4 T cells differ in their requirements for T cell receptor versus costimulatory signals, J. Immunol. 157 (1996) 3280.
23. J.P. Griffith, J.L. Kim, E.E. Kim, M.D. Sintchak, J.A. Thomson, M.J. Fitzgibbon, M.A. Fleming, P.R. Caron, K. Hsiao, M.A. Navia, X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex, Cell 82 (1995) 507.
24. C.R. Kissinger, H.E. Parge, D.R. Knighton, C.T. Lewis, L.A. Pelletier, A. Tempczyk, V.J. Kalish, K.D. Tucker, R.E. Showalter, E.W. Moomaw, et al., Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex, Nature 378 (1995) 641.
25. C.S. Hemenway, J. Heitman, Calcineurin, structure, function, and inhibition, Cell Biochem. Biophys. 30 (1999) 115.
26. J.C. Lawrence, R.T. Abraham, PHAS-I/4E-BPs as regulators of mRNA translation and cell proliferation, Trends Biochem. Sci. 22 (1997) 345.
27. B.E. Clurman, W.S. Hayward, Multiple proto-oncogene activations in avian leukosis virus-induced lymphomas: Evidence for stage-specific events, Mol. Cell Biol. 9 (1989) 2651.
28. W. Tam, D. Ben-Yehuda, W.S. Hayward, bic, a novel gene activated by proviral insertions in avian leukosis virus-induced lymphomas, is likely to function through its noncoding RNA, Mol. Cell Biol. 17 (1997) 1490.
29. T. Gura, A silence that speaks volumes, Nature 404 (2000) 804.
30. C.T. Kuo, M.L. Veselits, J.M. Leiden, LKLF: A transcriptional regulator of single-positive T cell quiescence and survival, Science 277 (1997) 1986.
31. + T cells, J. Immunol. 166 (2001) 7335.
32. D.S. Askew, F. Xu, New insights into the function of noncoding RNA and its potential role in disease pathogenesis, Histol. Histopathol. 14 (1999) 235.
33. V.A. Erdmann, M.Z. Barciszewska, A. Hochberg, N. de Groot, J. Barciszewski, Regulatory RNAs, Cell. Mol. Life Sci. 58 (2001) 960.
34. C.J. Brown, A. Ballabio, J.L. Rupert, R.G. Lafreniere, M. Grompe, R. Tonlorenzi, H.F. Willard, A gene from the region of the human X inactivation centre is expressed exclusively from the inactive X chromosome, Nature 349 (1991) 38.
35. M.F. Lyon, The X-inactivation center and X-chromosome imprinting, Eur. J. Human Genet. 2 (1994) 255.
36. G.D. Penny, G.F. Kay, S.A. Sheardown, S. Rastan, N. BrockdorH, Requirement for Xist in X-chromosome inactivation, Nature 379 (1996) 131.